Table 1 |
|
| Clinicopathologic characteristics of 126 patients with bladder cancerX―±s | |
| Clinical features | N (%) |
| Mean age (minimum-maximum) | 66.8 (43–81) |
| Sex | |
| Male | 87 (69.0) |
| Female | 39 (31.0) |
| Stage | |
| Ta | 48 (38.1) |
| T1 | 46 (36.5) |
| ≥T2 | 32 (25.4) |
| Grade | |
| LMP | 32 (25.4) |
| LG | 43 (34.1) |
| HG | 51 (40.5) |
| Carcinoma in situ | 26 (20.6) |
| Surgical procedure | |
| TUR | 90 (71.4) |
| Cystectomy | 36 (28.6) |
| Recurrence | 43 (34.1) |
| pTa | 11 (25.6) |
| pT1 | 23 (53.5) |
| ≥pT2 | 9 (20.9) |
| Progression | 26 (18.8) |
| pTa | 6 (23.1) |
| pT1 | 11 (42.3) |
| ≥pT2 | 9 (34.6) |
| Death | 65 (51.6) |
| pTa | 12 (18.5) |
| pT1 | 30 (46.2) |
| ≥pT2 | 23 (35.4) |
TUR; transurethral resection; LMP: low malignant potential; LG: low grade; HG: high grade; Carcinoma in situ (CIS): 2 isolated CIS and 14 concomitant CIS.
Wang et al. Diagnostic Pathology 2012 7:159 doi:10.1186/1746-1596-7-159
